JP Morgan Chase
NMTC icon

JP Morgan Chase’s NeuroOne Medical Technologies NMTC Stock Holding History

JP Morgan Chase’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$96 Buy
+88
New +$165 ﹤0.01% 7840
2025
Q2 		– Sell
-10
Closed -$52 – 7466
2025
Q1 		$52 Sell
10
-1
-9% -$6 ﹤0.01% 6981
2024
Q4 		$55 Sell
11
-1
-8% -$5 ﹤0.01% 7110
2024
Q3 		$68 Buy
12
+2
+20% +$10 ﹤0.01% 7066
2024
Q2 		$46 Buy
10
+1
+11% +$6 ﹤0.01% 7042
2024
Q1 		$66 Buy
9
+2
+29% +$15 ﹤0.01% 6977
2023
Q4 		$62 Buy
7
+3
+75% +$22 ﹤0.01% 7176
2023
Q3 		$23 Buy
+4
New +$27 ﹤0.01% 7143

Other funds holding NMTC

Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Belpointe Asset Management
Belpointe Asset Management Reno, Nevada $3.63B AUM 17.81% 1-Year Est. Return
Princeton Global Asset Management
Princeton Global Asset Management Princeton, New Jersey $692M AUM 20.31% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

JP Morgan Chase's NMTC Position: Q3 2026 in Review

JP Morgan Chase opened a new position in NeuroOne Medical Technologies (NMTC) in Q3 2026: 88 shares worth $96. The stake represents ﹤0.01% of the portfolio and ranks #7840 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in NMTC as recently as Q1 2025.

JP Morgan Chase first reported a position in NMTC in Q3 2023 and has held it in 8 quarters since. 13 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

  • JP Morgan Chase held 88 shares of NeuroOne Medical Technologies worth $96 as of Q3 2026.
  • NeuroOne Medical Technologies was a new JP Morgan Chase position in Q3 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7840 holding.
  • JP Morgan Chase first reported a position in NeuroOne Medical Technologies in Q3 2023 and has held it in 8 quarters since.
  • 13 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.